Clinical Trial Update: Dose Optimisation of Stavudine for the Treatment of HIV Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports dose optimisation of stavudine for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Human Immunodeficiency Virus Infection

Drugs mentioned

• stavudine (stavudine)

Snippet

Sponsor: Willem Daniel Francois Venter | Conditions: Acquired Immune Deficiency Syndrome, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED